SecBot SecBot

TOI

Starling Oncology, Inc.
Nasdaq· Services-Offices & Clinics of Doctors of Medicine· Inc. DE· CIK 0001799191 Biotech & Drug Discovery
Former ticker of Starling Oncology, Inc. · STLN stock page →
—
Market cap
$512.9M
Small cap
Median target
$8.00
range $7.00–10.00
Short interest
7.15M
≈7.2% of shares · −1.6%
Days to cover
4.8
at average volume
Insider net
+$2.0M
1 buyer · 2 sellers · 12 mo
Filing reports
10
analyzed by SecBot
SecBot read MIXED 2 reports · 90 days
Balance 0 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 2/2
Strongest NEUTRAL Oncology Institute, Inc. is rebranding as Starling Oncology, Inc. effective July 28, 2026, with its Nasdaq…
All reports →

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $2.6M at an average $3.35. 2 insiders sold $611.6K.

  • EstimatesRISING

    Current-quarter EPS estimate −$0.068 → −$0.064 over 90 days. 1 up, 0 down in 30 days.

  • Short sellersSTEADY

    Short interest −1.6% to 7.15M shares. 4.8 days to cover, ≈7.2% of shares.

The Street

last action Jul 2026
Recent actions
DateFirmActionRating
Jul 9, 2026BTIG
MAINTAIN
MAINTAINBuy
Jul 6, 2026Lake Street
INITIATE
INITIATEBuy
Jun 17, 2026Needham
MAINTAIN
MAINTAINBuy
Jun 8, 2026BTIG
MAINTAIN
MAINTAINBuy
Mar 13, 2026B. Riley Securities
MAINTAIN
MAINTAINBuy
Mar 13, 2026Needham
REITERATE
REITERATEBuy
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 6, 2026
Earnings date
TOI Q2 2026 Earnings Scheduled — 2026-08-06
Aug 4, 2026
Listing
Delisted: TOI — removed from the Nasdaq symbol directory
The Oncology Institute, Inc. - Common Stock
May 7, 2026
Earnings date
TOI Q1 2026 Earnings Scheduled — 2026-05-07
May 6, 2026
Earnings date
TOI Q1 2026 Earnings After Market Close — 2026-05-06
Apr 27, 2026
Earnings
The Oncology Institute Announces First Quarter 2026 Earnings Release Date and Conference Call
CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology…

Insider ledger

Form 4
$2.6M
bought · 1 insider
$611.6K
sold · 2 insiders
DateInsiderTypeValue
Jul 27, 2026
Kaushal Mohit
Director
AWARD33,133 sh
Jul 27, 2026
STOLPER MARK
Director
AWARD31,124 sh
Jul 27, 2026
McGeorge Anne
Director
AWARD41,165 sh
Jul 27, 2026
Pacala Mark L
Director
AWARD30,120 sh
Jul 27, 2026
Hively Brad
Director
AWARD27,108 sh
Jul 27, 2026
TZOUMAKAS KIMBERLY JO
Director
AWARD29,116 sh
Jul 27, 2026
Johnson Karen Marie
Director
AWARD31,124 sh
Jul 21, 2026
Chernett Jorey
10%+ Owner
BUY$94.9K

Earnings setup

Estimates
−$0.06
EPS estimate, this quarter
+5%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Next Q-$0.04-$0.06–$0.00+20.0%$171.2M
Current Q-$0.06-$0.07–-$0.06+1.5%$155.2M
Next FY-$0.03-$0.12–$0.14+68.8%$825.5M
Current FY-$0.14-$0.18–-$0.09+8.0%$655.5M

Short side

FINRA· Jul 31, 2026
7,154,907
shares short
-1.6%
vs prior settlement
4.8
days to cover
≈7.2%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 6, 2026 Earnings calendar
TOI Q2 2026 Earnings Scheduled — 2026-08-06
Aug 3, 2026 SEC
Oncology Institute, Inc. is rebranding as Starling Oncology, Inc. effective July 28, 2026, with its Nasdaq ticker…
8-K — Impact 2/10
Jul 27, 2026 Insider
Kaushal Mohit was granted 33,133 shares
Director
Jul 27, 2026 Insider
STOLPER MARK was granted 31,124 shares
Director
Jul 27, 2026 Insider
McGeorge Anne was granted 41,165 shares
Director
Jul 22, 2026 SEC
Jorey Chernett, a 10% owner of Oncology Institute, purchased 18,000 shares at $5.27 for $95,000 on July 21, 2026. The…
INSIDER-BUY — Impact 2/10
Jul 22, 2026 SEC
A mixed insider cluster at Oncology Institute, Inc. (TOI) saw CMO Yale Podnos sell $116K in shares on July 14 while…
CLUSTER — Impact 2/10
Mar 12, 2026 Press
The Oncology Institute (TOI) reported strong fourth-quarter and full-year 2025 financial results, with Q4 revenue up…
Impact 8/10

SecBot reports

10 filings · 1 press release · 1 bullish · 0 bearish · 1 mixed · 8 neutral
All TOI filing & press-release reports (11)